The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study.

Helena Gensmyr-SingerMårten WernerPontus Karling

Published in: Therapeutic advances in gastroenterology (2024)

Treatment with a low dose of thioguanine is well-tolerated in patients with IBD and had a significantly higher drug-survival than conventional thiopurines.

Keyphrases

low dose
patients with inflammatory bowel disease
high dose
free survival
adverse drug
combination therapy